Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: Effect of naïve and memory T-cell subsets

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Tinago, Willard ^a,b   Coghlan, Elizabeth ^a   Macken, Alan ^a   McAndrews, Julie ^c   Doak, Brenda ^c   Prior Fuller, Charlotte ^c   Lambert, John S ^a,c   Sheehan, Gerard J ^a,c   Mallon, Patrick W G ^a,c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA; CD45 ANTIGEN; L SELECTIN;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELL POPULATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; TREATMENT DURATION; CELL COUNT; HIV INFECTIONS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED; STATISTICAL MODEL;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; L-SELECTIN; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 84901244816     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097011     Document Type: Article

References (33)

1. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, et al. (2011) CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 186: 2106-2116.
2. Hel Z, McGhee JR, Mestecky J (2006) HIV infection: first battle decides the war. Trends Immunol 27: 274-281. (Pubitemid 44183640)
3. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F (2000) T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 1: 285-289.
4. Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, et al. (2000) Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 97: 13778-13783.
5. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194: 1731-1741. (Pubitemid 34028653)
6. Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, et al. (1998) Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 187: 1295-1303. (Pubitemid 28189118)
7. Margolick JB, Munoz A, Donnenberg AD, Park LP, Galai N, et al. (1995) Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med 1: 674-680.
8. Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78: 5535-5545. (Pubitemid 38661640)
9. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, et al. (1995) Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest 95: 2054-2060.
10. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ et al (1997) Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection Ann Intern Med 126: 946-954. (Pubitemid 27255797)
11. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, et al. (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116. (Pubitemid 27450659)
12. Douek DC, Koup RA, McFarland RD, Sullivan JL, Luzuriaga K (2000) Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis 181: 1479-1482. (Pubitemid 30252560)
13. Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, et al. (1999) HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5: 518-525. (Pubitemid 29220210)
14. Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, et al. (2013) Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One 8: e77665.
15. Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, et al. (2013) The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 66: 57-66.
16. Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, et al. (2010) Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy. Antivir Ther 15: 165-175.
17. Alvarez-Larran A, Jover L, Marin P, Petriz J (2002) A multicolor, no-lyse nowash assay for the absolute counting of CD34+ cells by flow cytometry. Cytometry 50: 249-253.
18. Menéndez P, Redondo O, Rodriguez A, Lopez-Berges MC, Ercilla G, et al. (1998) Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 34: 264-271.
19. Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, et al. (2011) Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis 203: 992-1001.
20. Yamaoka M, Kusunoki Y, Kasagi F, Hayashi T, Nakachi K, et al. (2004) Decreases in percentages of naive CD4 and CD8 T cells and increases in percentages of memory CD8 T-cell subsets in the peripheral blood lymphocyte populations of A-bomb survivors. Radiat Res 161: 290-298. (Pubitemid 40797071)
21. Sainz T, Serrano-Villar S, Diaz L, Gonzalez Tome MI, Gurbindo MD, et al. (2013) The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS 27: 1513-1516.
22. Buggert M, Frederiksen J, Noyan K, Svard J, Barqasho B, et al. (2014) Multiparametric Bioinformatics Distinguish the CD4/CD8 Ratio as a Suitable Laboratory Predictor of Combined T Cell Pathogenesis in HIV Infection. J Immunol.
23. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, et al. (2013) Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 27: 973-979.
24. Serrano-Villar S, Moreno S, Fuentes-Ferrer M, Sanchez-Marcos C, Avila M, et al. (2014) The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med 15: 40-49.
25. Serrano-Villar S, Perez-Elias MJ, Dronda F, Casado JL, Moreno A, et al. (2014) Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio. PLoS One 9: e85798.
26. Cotter AG, Mallon PW (2013) The effects of untreated and treated HIV infection on bone disease. Curr Opin HIV AIDS.
27. Hearps AC, Angelovich TA, Jaworowski A, Mills J, Landay AL, et al. (2011) HIV infection and aging of the innate immune system. Sex Health 8: 453-464.
28. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, et al. (1995) CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95: 2061-2066.
29. Condotta SA, Rai D, James BR, Griffith TS, Badovinac VP (2013) Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J Immunol 190: 1991-2000.
30. La Gruta NL, Thomas PG (2013) Interrogating the relationship between naive and immune antiviral T cell repertoires. Curr Opin Virol 3: 447-451.
31. La Gruta NL, Rothwell WT, Cukalac T, Swan NG, Valkenburg SA, et al. (2010) Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest 120: 1885-1894.
32. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, et al. (2013) Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 381: 2109-2117.
33. Amadori A, Zamachi R, De Silvestro G, Forza G, Cavatton G, et al (1995) Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1: 1240-1241.